Scientific Advisors

Our Founder & Chairman

Lately at Benevolent

Our latest updates.

News
Rob Quinn to join BenevolentAI as Chief Financial Officer
Rob Quinn to join BenevolentAI as Chief Financial Officer to guide the company's growth and financial direction.
Oct 21, 2020
News
NIAID releases additional data validating BenevolentAI’s hypothesis for baricitinib as a treatment for COVID-19 patients in large-scale randomised control trial
Additional data from the ACTT-2 randomised control trial shows reduced time to recovery and improved clinical outcomes for patients with COVID-19.
Oct 9, 2020
News
BenevolentAI welcomes Professor Russ Altman as scientific advisor
As a scientific advisor at BenevolentAI, Professor Russ Altman will help our scientists to further push the boundaries of machine learning applied drug discovery.
Oct 1, 2020